Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00602290 · ClinicalTrials.gov registry record · Phase 4
Effectiveness of Methylphenidate in Improving Cognition and Function in Older Adults With Depression
A Phase 4 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 4
- Development phase
- 181
- Enrollment target
NCT00602290 is a Phase 4 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 181 participants.
The verdict
NCT00602290, a Phase 4 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 181 participants
- Enrollment target
Study Summary
This study will evaluate the safety and effectiveness of methylphenidate in improving cognition and function in older adults with depression.
Interventions
- DRUG Placebo
- DRUG Citalopram
- DRUG Methylphenidate (MPH)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2008-02 |
| Est. Completion | 2013-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00602290
The ClinicalTrials.gov registry entry for NCT00602290 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00602290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00602290 about?
NCT00602290 is a clinical study titled "Effectiveness of Methylphenidate in Improving Cognition and Function in Older Adults With Depression". This study will evaluate the safety and effectiveness of methylphenidate in improving cognition and function in older adults with depression.
What is the current status of trial NCT00602290?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 181 participants. The study started on 2008-02. Estimated completion is 2013-02.
What interventions are being tested in trial NCT00602290?
The interventions under investigation include: Placebo (DRUG), Citalopram (DRUG), Methylphenidate (MPH) (DRUG).
Who is sponsoring clinical trial NCT00602290?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.